KDR and hepatocellular carcinoma: Indeed, it has been recently reported in a preclinical HCC model [41] that dual PD-1 and VEGFR blockade increases CD8 T-cell infiltration, associated with a higher therapeutic efficacy, suggesting that vaccine-induced T-cells may benefit from this property of VEGF blockade.